Company intelligence / Profile preview

Ourobio

Charlottesville, Virginia, United States
Ownership
Private
Employees
~5
Development stage
Other
01

Overview

Ourobio is a private synthetic biology and biomaterials company developing engineered-microbe fermentation processes that convert industrial and agricultural byproducts into bio-based, biodegradable materials. The company focuses on circular-economy applications rather than therapeutics, with an emphasis on polyhydroxyalkanoate-based plastic resins, pigments, and additives intended to replace petrochemical-derived materials. Ourobio originated from the University of Virginia iGEM project "Transfoam" in 2019 and was spun out in March 2020. Its platform is designed to co-produce complementary biomaterials in a single fermentation process, including initial work using dairy byproducts such as whey as feedstock. The company appears to be an early-stage private startup working with manufacturers and brands on sustainable materials and packaging applications.

Modalities
Biologic
Industry
Non-Drug Biotech
02

Partnerships

Plastic converters and brands for colored PHA-based biopolymer blends

Beyond the preview

Go deeper on Ourobio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ourobio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call